Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pfizer (PFE)
NYSE:PFE
Pfizer (PFE) Stock Price & Analysis
28,968 Followers
PFE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$24.82 - $35.80
Previous Close$28.22
Volume21.99M
Average Volume (3M)38.15M
Market Cap
$159.91B
Enterprise Value$217.80B
Total Cash (Recent Filing)$11.93B
Total Debt (Recent Filing)$69.54B
Price to Earnings (P/E)―
Beta0.40
Next Earnings
Jul 30, 2024EPS Estimate
$0.46Next Dividend Ex-Date
Jul 26, 2024Dividend Yield5.93%
Share Statistics
EPS (TTM)-0.06
Shares Outstanding5,666,592,898
10 Day Avg. Volume33,289,791
30 Day Avg. Volume38,152,010
Standard Deviation0.08
R-Squared0.20
Alpha-0.00747
Financial Highlights & Ratios
Price to Book (P/B)-3.95
Price to Sales (P/S)11.03
Price to Cash Flow (P/CF)36.10
P/FCF Ratio35.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.95
Enterprise Value/Gross Profit6.49
Enterprise Value/Ebitda38.99
Forecast
1Y Price Target
$33.50Price Target Upside20.37% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
Pfizer News
PremiumCompany Announcements
Pfizer Enhances Board with Cyrus Taraporevala’s AppointmentBulls Say, Bears Say
Bulls Say
Cost ManagementCost efficiencies across the manufacturing network contributed to the higher gross margin.
EarningsPfizer reported EPS of $0.82, driven by one-time Paxlovid revenue upside and much lower than anticipated COGS.
Strategic InitiativesPfizer’s pivot to three commercial verticals facilitates more rapid communication between sales and management so that market dynamics can be reflected in the company’s strategy in real-time.
Bears Say
Clinical Trial ResultsThe CIFFREO Ph3 trial did not meet its primary endpoint of improvement in motor function among boys 4-7 years of age treated with the gene therapy compared to placebo.
Market PerformanceComirnaty sales underperformed despite the company setting low expectations.
Revenue And ProfitabilityPfizer will struggle to grow late decade, and a 5-year revenue and EPS growth of -1% is projected.
---
Ownership Overview
0.26% Insiders
20.92% Mutual Funds
20.64% Other Institutional Investors
58.17% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PFE FAQ
What was Pfizer’s price range in the past 12 months?
Pfizer lowest stock price was $24.82 and its highest was $35.80 in the past 12 months.
What is Pfizer’s market cap?
Currently, no data Available
When is Pfizer’s upcoming earnings report date?
Pfizer’s upcoming earnings report date is Jul 30, 2024 which is in 27 days.
How were Pfizer’s earnings last quarter?
Pfizer released its earnings results on May 01, 2024. The company reported $0.82 earnings per share for the quarter, beating the consensus estimate of $0.516 by $0.304.
Is Pfizer overvalued?
According to Wall Street analysts Pfizer’s price is currently Undervalued.
Does Pfizer pay dividends?
Pfizer pays a Quarterly dividend of $0.42 which represents an annual dividend yield of 5.93%. See more information on Pfizer dividends here
What is Pfizer’s EPS estimate?
Pfizer’s EPS estimate is $0.46.
How many shares outstanding does Pfizer have?
Pfizer has 5,666,593,000 shares outstanding.
What happened to Pfizer’s price movement after its last earnings report?
Pfizer reported an EPS of $0.82 in its last earnings report, beating expectations of $0.516. Following the earnings report the stock price went up 6.101%.
Which hedge fund is a major shareholder of Pfizer?
Among the largest hedge funds holding Pfizer’s share is Diamond Hill Capital Management Inc. It holds Pfizer’s shares valued at 447M.
---
Pfizer Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$33.50 (20.37% Upside)
$33.50 (20.37% Upside)
Blogger Sentiment
Bullish
PFE Sentiment 77%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 16.1M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days >0.1%
Last 30 Days <0.1%
Last 30 Days <0.1%
News Sentiment
Bullish
Bullish news 67%
Bearish news 33%
Bearish news 33%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-18.76%
12-Months-Change
Fundamentals
Return on Equity
-0.30%
Trailing 12-Months
Asset Growth
13.02%
Trailing 12-Months
Company Description
Pfizer
Pfizer Inc. develops, manufactures and sells healthcare products, including innovative medicines and vaccines. Its key focus areas include oncology, inflammation & immunology, rare disease, vaccines and internal medicine. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
---
PFE Company Deck
---
PFE Earnings Call
Q1 2024
0:00 / 0:00
---
PFE Revenue Breakdown
52.29% Primary Care
25.59% Specialty Care
19.88% Oncology
2.24% BUSINESS INNOVATION
---
PFE Stock 12 Month Forecast
Average Price Target
$33.50
▲(20.37% Upside)
Technical Analysis
Best Analysts Covering PFE
1 Year
1 Year Success Rate
26/34 ratings generated profit
1 Year Average Return
+5.59%
initiated a buy rating 4 months ago
Copying Vamil Divan's trades and holding each position for 1 Year would result in 76.47% of your transactions generating a profit, with an average return of +5.59% per trade.
---